| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |